Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer.
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer. N Engl J Med. 2016 Feb 25; 374(8):738-48.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Bevacizumab
Carboplatin
Carboplatin
Disease-Free Survival
Disease-Free Survival
Drug Administration Schedule
Drug Administration Schedule
Female
Female
Humans
Humans
Infusions, Intravenous
Infusions, Intravenous
Intention to Treat Analysis
Intention to Treat Analysis
Middle Aged
Middle Aged
Ovarian Neoplasms
Ovarian Neoplasms
Paclitaxel
Paclitaxel
authors with profiles
Joan L Walker